A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, July 9, 2025 (HealthDay News) — A common virus once thought harmless to ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Groundbreaking new research released from Northwestern Medicine discovered that a usually harmless virus in the blood, may be ...

Parkinsons disease and similar disorders are movement disorders characterised by various nonmotor issues The end-stage poses multifaceted challenges across medical emotional daily-life and caregiver d ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.